Per Protocol Analysis

Per Protocol Analysis - Axcellant

Per Protocol Analysis

  1. lut 28, 2025

What Does the 'Per Protocol Analysis’ Mean?

Per Protocol Analysis is a method of analyzing clinical trial data that includes only participants who fully complied with the study protocol. This approach focuses on evaluating the treatment effect under ideal conditions, considering only those subjects who adhered to all aspects of the trial design. It excludes participants who deviated from the protocol, such as those who dropped out or did not follow the prescribed intervention.

The primary purpose of Per Protocol Analysis is to assess the efficacy of a treatment when administered exactly as intended. While this method can provide insights into the maximum potential benefit of an intervention, it may not reflect real-world effectiveness due to its selective nature. Per Protocol Analysis is often conducted alongside Intent-to-Treat analysis to provide a comprehensive understanding of trial results.

Why Is the 'Per Protocol Analysis’ Important in Clinical Research?

Per Protocol Analysis is crucial in clinical research as it provides a measure of the maximum potential efficacy of a treatment under optimal conditions. This approach helps researchers understand how well an intervention works when administered exactly as intended, which can be valuable for regulatory submissions and determining the best-case scenario for treatment outcomes.

Additionally, Per Protocol Analysis serves as a complementary method to Intent-to-Treat analysis, offering a more complete picture of trial results. By comparing findings from both analyses, researchers can gain insights into the impact of protocol deviations and non-adherence on treatment effectiveness, which is essential for interpreting and generalizing study results to real-world clinical practice.

Good Practices and Procedures

  1. Clearly define protocol deviation criteria and adherence thresholds in the statistical analysis plan before unblinding the study data.
  2. Conduct sensitivity analyses using different adherence cutoffs to assess the robustness of the Per Protocol results.
  3. Document and report all reasons for exclusion from the Per Protocol population to maintain transparency.
  4. Compare baseline characteristics between the Per Protocol and Intent-to-Treat populations to identify potential selection bias.
  5. Consider using statistical methods, such as inverse probability weighting, to adjust for potential confounding in the Per Protocol analysis.

Related Terms

Resources

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…

One trial is no longer enough. Regulators on both sides of the Atlantic are building a new model of clinical evidence

The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…

Imaging Core Lab in Nuclear Medicine: Standardization, Quality Control, and Regulatory Alignment in Clinical Trials 

Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…